Importance of baseline distribution of proteinuria in renal outcomes trials: lessons from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study (Q46472704)
Jump to navigation
Jump to search
scientific article published on 4 May 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Importance of baseline distribution of proteinuria in renal outcomes trials: lessons from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study |
scientific article published on 4 May 2005 |
Statements
1 reference
Importance of baseline distribution of proteinuria in renal outcomes trials: lessons from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study (English)
1 reference
Zhongxin Zhang
1 reference
Shahnaz Shahinfar
1 reference
William F Keane
1 reference
Denise Ramjit
1 reference
Tania Z Dickson
1 reference
Gilbert W Gleim
1 reference
Carl Erik Mogensen
1 reference
Dick de Zeeuw
1 reference
Barry M Brenner
1 reference
Steven M Snapinn
1 reference
4 May 2005
1 reference
16
1 reference
6
1 reference
1775-1780
1 reference